Drug Shortage Report for ACETAZOLAMIDE FOR INJECTION, USP
| Report ID | 185664 |
| Drug Identification Number | 02358328 |
| Brand name | ACETAZOLAMIDE FOR INJECTION, USP |
| Common or Proper name | ACETAZOLAMIDE FOR INJECTION, USP |
| Company Name | STERIMAX INC |
| Market Status | MARKETED |
| Active Ingredient(s) | ACETAZOLAMIDE |
| Strength(s) | 500MG |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 1 vial |
| ATC code | S01EC |
| ATC description | ANTIGLAUCOMA PREPARATIONS AND MIOTICS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2023-02-28 |
| Estimated end date | 2023-03-06 |
| Actual end date | 2023-03-02 |
| Shortage status | Resolved |
| Updated date | 2023-03-03 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2770 PORTLAND DRIVE OAKVILLE, ONTARIO CANADA L6H 6R4 |
| Company contact information | 1-800-881-3550 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2023-03-03 | English | Compare |
| v5 | 2023-03-02 | French | Compare |
| v4 | 2023-03-02 | English | Compare |
| v3 | 2023-03-01 | English | Compare |
| v2 | 2023-02-28 | French | Compare |
| v1 | 2023-02-28 | English | Compare |
Showing 1 to 6 of 6